Published in J Mol Cell Cardiol on July 31, 2007
The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress | NCT00250185
Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2008) 2.17
Hydrogen sulfide chemical biology: pathophysiological roles and detection. Nitric Oxide (2013) 1.56
Mechanisms of nitrite bioactivation. Nitric Oxide (2013) 1.22
Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite. J Biol Chem (2009) 1.21
Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol (2015) 1.19
Myocardial protection by nitrite. Cardiovasc Res (2009) 1.16
Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotection. J Mol Cell Cardiol (2009) 1.14
Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation. Redox Biol (2013) 1.09
Nitrite directly vasodilates hypoxic vasculature via nitric oxide-dependent and -independent pathways. Br J Pharmacol (2009) 1.07
Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how. Nitric Oxide (2013) 1.07
Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2. J Biol Chem (2014) 1.05
Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits. Eur J Nutr (2011) 1.03
Clinical translation of nitrite therapy for cardiovascular diseases. Nitric Oxide (2009) 1.01
Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition (2011) 1.00
Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. Am J Physiol Heart Circ Physiol (2010) 0.95
Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases. J Biol Inorg Chem (2010) 0.94
Nitrite in organ protection. Br J Pharmacol (2014) 0.93
Nitrates and nitrites in the treatment of ischemic cardiac disease. Cardiol Rev (2010) 0.92
Inorganic nitrite supplementation for healthy arterial aging. J Appl Physiol (1985) (2014) 0.91
The detection of the nitrite reductase and NO-generating properties of haemoglobin by mitochondrial inhibition. Cardiovasc Res (2010) 0.89
Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction. Circ Res (2014) 0.89
Nitrite as a mediator of ischemic preconditioning and cytoprotection. Nitric Oxide (2011) 0.88
The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial. BMJ Open (2013) 0.87
Reciprocal regulation of cellular nitric oxide formation by nitric oxide synthase and nitrite reductases. Med Sci Monit (2011) 0.85
Mitochondria as metabolizers and targets of nitrite. Nitric Oxide (2009) 0.85
Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite. Br J Pharmacol (2013) 0.84
Nitrate/Nitrite as Critical Mediators to Limit Oxidative Injury and Inflammation. Antioxid Redox Signal (2015) 0.84
Parallel evolution of nitric oxide signaling: diversity of synthesis and memory pathways. Front Biosci (Landmark Ed) (2011) 0.83
A selenium-dependent xanthine dehydrogenase triggers biofilm proliferation in Enterococcus faecalis through oxidant production. J Bacteriol (2011) 0.82
The redox interplay between nitrite and nitric oxide: From the gut to the brain. Redox Biol (2013) 0.81
Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord (2011) 0.81
Impact of mitochondria on nitrite metabolism in HL-1 cardiomyocytes. Front Physiol (2013) 0.80
Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases. J Biol Inorg Chem (2015) 0.80
Chemical nature and reaction mechanisms of the molybdenum cofactor of xanthine oxidoreductase. Curr Pharm Des (2013) 0.80
Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout. J Biol Inorg Chem (2014) 0.80
Antioxidant effects of ethyl acetate extract of Desmodium gangeticum root on myocardial ischemia reperfusion injury in rat hearts. Chin Med (2010) 0.79
NO-Rich Diet for Lifestyle-Related Diseases. Nutrients (2015) 0.79
Heart failure management: the present and the future. Antioxid Redox Signal (2009) 0.77
A new paradigm for XOR-catalyzed reactive species generation in the endothelium. Pharmacol Rep (2015) 0.77
The Reemergence of Nitrite as a Beneficial Agent in the Treatment of Ischemic Cardiovascular Diseases. Asian J Exp Biol Sci (2010) 0.76
Ishemia-reperfusion enhances GAPDH nitration in aging skeletal muscle. Aging (Albany NY) (2011) 0.75
Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies. Basic Res Cardiol (2016) 0.75
Nitrite administration improves sepsis-induced myocardial and mitochondrial dysfunction by modulating stress signal responses. J Anesth (2017) 0.75
Nitric Oxide and Related Aspects Underlying Angina. Open Cardiovasc Med J (2017) 0.75
Dietary supplementation with sodium nitrite can exert neuroprotective effects on global cerebral ischemia/reperfusion in mice. J Anesth (2015) 0.75
ATP-regulated K+ channels in cardiac muscle. Nature (1983) 10.05
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med (2003) 8.95
Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther (1953) 8.48
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest (2005) 4.14
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res (1997) 3.41
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci U S A (2004) 3.23
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest (2005) 3.08
Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med (2003) 2.83
Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol (2006) 2.75
The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J Biol Chem (2005) 2.34
Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem (1981) 2.29
Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res (1999) 2.08
Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med (2002) 2.06
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem (2000) 1.93
K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol (2005) 1.84
Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J Biol Chem (1975) 1.77
Nitric oxide synthase reduces nitrite to NO under anoxia. Cell Mol Life Sci (2007) 1.73
Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol (1988) 1.62
Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc Natl Acad Sci U S A (2002) 1.49
Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. J Biol Chem (2004) 1.48
Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun (1998) 1.42
The measurement of blood and plasma nitrite by chemiluminescence: pitfalls and solutions. Free Radic Biol Med (2006) 1.38
Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem (1994) 1.35
Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J Clin Invest (1988) 1.29
ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res (1991) 1.29
A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med (1989) 1.29
A new route to peroxynitrite: a role for xanthine oxidoreductase. FEBS Lett (2000) 1.09
Pharmacokinetics of sodium nitrite-induced methemoglobinemia in the rat. Drug Metab Dispos (2002) 1.02
Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res (2006) 1.01
Xanthine oxidase catalyzes anaerobic transformation of organic nitrates to nitric oxide and nitrosothiols: characterization of this mechanism and the link between organic nitrate and guanylyl cyclase activation. J Biol Chem (2005) 1.00
Preconditioning in immature rabbit hearts: role of KATP channels. Circulation (1999) 0.99
Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90. J Mol Cell Cardiol (2005) 0.98
Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am J Physiol (1999) 0.96
Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. Am J Physiol (1995) 0.95
NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J Mol Cell Cardiol (2007) 0.91
Reduction of organic nitrites to nitric oxide catalyzed by xanthine oxidase: possible role in metabolism of nitrovasodilators. Biochem Biophys Res Commun (2000) 0.88
K(ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K(ATP) channels, free radicals and MEK1/2. J Mol Cell Cardiol (2003) 0.87
Suicide inactivation of xanthine oxidoreductase during reduction of inorganic nitrite to nitric oxide. Biochem J (2001) 0.80
The proportion of xanthine oxidase activity of total xanthine oxidoreductase activity in situ remains constant in rat liver under various (patho)physiological conditions. Hepatology (1996) 0.80
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest (2005) 4.14
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest (2005) 3.08
The emerging biology of the nitrite anion. Nat Chem Biol (2005) 2.88
Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol (2006) 2.75
Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res (2004) 2.40
Prospective echocardiographic diagnosis and surgical repair of anomalous origin of a coronary artery from the opposite sinus with an interarterial course. J Am Coll Cardiol (2003) 2.34
The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J Biol Chem (2005) 2.34
Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat Chem Biol (2007) 2.30
Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation (2013) 2.24
Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am J Physiol Heart Circ Physiol (2006) 2.17
Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev (2009) 2.15
Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol (2012) 2.10
Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant (2011) 2.03
S-Nitrosothiols: cellular formation and transport. Free Radic Biol Med (2005) 1.94
Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J Mol Cell Cardiol (2002) 1.87
Fatty acid transduction of nitric oxide signaling. Nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor. J Biol Chem (2005) 1.75
Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J (2012) 1.71
Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci U S A (2004) 1.68
Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat (2006) 1.68
Aortic valve replacement in neonates and infants: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc Surg (2012) 1.63
Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J Biol Chem (2005) 1.61
Transduction of NO-bioactivity by the red blood cell in sepsis: novel mechanisms of vasodilation during acute inflammatory disease. Blood (2004) 1.61
The mechanism of transmembrane S-nitrosothiol transport. Proc Natl Acad Sci U S A (2004) 1.61
Concerted nitric oxide formation and release from the simultaneous reactions of nitrite with deoxy- and oxyhemoglobin. J Biol Chem (2007) 1.57
Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases! Pharmacol Ther (2009) 1.56
Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol (2007) 1.54
Medium-term outcomes of Kawashima and completion Fontan palliation in single-ventricle heart disease with heterotaxy and interrupted inferior vena cava. Ann Thorac Surg (2010) 1.53
Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats. Cardiovasc Res (2007) 1.52
Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. Am J Physiol Heart Circ Physiol (2006) 1.52
Characterization and application of the biotin-switch assay for the identification of S-nitrosated proteins. Free Radic Biol Med (2005) 1.48
The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol (2006) 1.48
Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther (2006) 1.46
Quality measures for congenital and pediatric cardiac surgery. World J Pediatr Congenit Heart Surg (2012) 1.45
Selective ATP-sensitive potassium channel openers: fact or fiction. J Mol Cell Cardiol (2003) 1.44
Copper dependence of the biotin switch assay: modified assay for measuring cellular and blood nitrosated proteins. Free Radic Biol Med (2008) 1.43
Editorial view: anesthetic preconditioning: serendipity and science. Anesthesiology (2002) 1.42
Leftward displacement of septum primum in hypoplastic left heart syndrome. Pediatr Cardiol (2012) 1.41
Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury. Am J Physiol Heart Circ Physiol (2006) 1.38
Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res (2006) 1.37
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. Circ Res (2004) 1.36
Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg (2006) 1.32
Opioid-induced preconditioning: recent advances and future perspectives. Vascul Pharmacol (2005) 1.30
Human gene copy number spectra analysis in congenital heart malformations. Physiol Genomics (2012) 1.30
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Basic Res Cardiol (2007) 1.30
Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol (2004) 1.27
Reaction between nitric oxide, glutathione, and oxygen in the presence and absence of protein: How are S-nitrosothiols formed? Free Radic Biol Med (2009) 1.26
Antioxidant defense responses to sleep loss and sleep recovery. Am J Physiol Regul Integr Comp Physiol (2004) 1.26
Late complications after Takeuchi repair of anomalous left coronary artery from the pulmonary artery: case series and review of literature. Pediatr Cardiol (2012) 1.26
Nitrite reductase activity of cytochrome c. J Biol Chem (2008) 1.25
Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. J Mol Cell Cardiol (2007) 1.24
GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol (2007) 1.24
Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res (2011) 1.22
The reaction between nitrite and hemoglobin: the role of nitrite in hemoglobin-mediated hypoxic vasodilation. J Inorg Biochem (2005) 1.22
Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res (2011) 1.21
Low NO concentration dependence of reductive nitrosylation reaction of hemoglobin. J Biol Chem (2012) 1.20
The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J Pharmacol Exp Ther (2007) 1.19
Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel. J Mol Cell Cardiol (2004) 1.18
Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes (2007) 1.18
Hemoglobin mediated nitrite activation of soluble guanylyl cyclase. Comp Biochem Physiol A Mol Integr Physiol (2005) 1.18
The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg (2008) 1.18
A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol (2003) 1.17
Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther (2007) 1.16
Changes in cerebral and somatic oxygenation during stage 1 palliation of hypoplastic left heart syndrome using continuous regional cerebral perfusion. J Thorac Cardiovasc Surg (2004) 1.14
The reaction between nitrite and oxyhemoglobin: a mechanistic study. J Biol Chem (2008) 1.14
Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotection. J Mol Cell Cardiol (2009) 1.14
Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Circ Res (2002) 1.14
Cause, timing, and location of death in the Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg (2012) 1.14
The chemical biology of S-nitrosothiols. Antioxid Redox Signal (2012) 1.13
Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12. Protein Sci (2009) 1.13
Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol (2004) 1.12
Proteomic methods for analysis of S-nitrosation. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.12
Formation and stability of S-nitrosothiols in RAW 264.7 cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.11
Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease. Blood (2012) 1.11
Optimal timing of the second stage of palliation for hypoplastic left heart syndrome facilitated through home monitoring, and the results of early cavopulmonary anastomosis. Cardiol Young (2006) 1.11
10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol (2009) 1.10
Measurements of nitric oxide on the heme iron and beta-93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation. Proc Natl Acad Sci U S A (2003) 1.09
Methodological vexation about thiol oxidation versus S-nitrosation -- a commentary on "An ascorbate-dependent artifact that interferes with the interpretation of the biotin-switch assay". Free Radic Biol Med (2006) 1.09
S-nitrosoglutathione. Biochim Biophys Acta (2013) 1.09
Home monitoring of infants after stage one palliation for hypoplastic left heart syndrome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2004) 1.09
Vascular dysfunction in a murine model of severe hemolysis. Blood (2008) 1.08
Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology (2010) 1.07
Risk and prevalence of developmental delay in young children with congenital heart disease. Pediatrics (2014) 1.06